Physician profile
Robert P Luberto
NPI 1760441174
$3,630.23
in general payments reported to CMS, 2019-2025
36 companies · $748 in 2025
The $748 reported for 2025 was more than what 87% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $859 · 2020: $77.04 · 2021: $477 · 2022: $540 · 2023: $367 · 2024: $562 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,676.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,518.59 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $264.26 | 2019-2025 | |
| Pfizer INC. | $223.96 | 2019-2025 | |
| Lilly USA, LLC | $203.74 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Stryker Corporation | $141.57 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.13 | 2019-2025 | Jardiance, Synjardy |
| Novo Nordisk INC | $101.07 | 2019-2025 | Wegovy |
| Axsome Therapeutics, INC. | $88.91 | 2023-2025 | Symbravo, Auvelity |
| Merck Sharp & Dohme LLC | $79.22 | 2019-2023 | Belsomra, Steglatro, Januvia |
| Glaxosmithkline, LLC. | $78.96 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $70.31 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $67.89 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.78 | 2019 | |
| Eisai INC. | $50.49 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $48.47 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $44.39 | 2021 | |
| Paratek Pharmaceuticals, INC. | $40.93 | 2025 | Nuzyra |
| Idorsia Pharmaceuticals US INC | $39.50 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $36.71 | 2019 | |
| Antares Pharma, INC. | $35.99 | 2019 | |
| Shire North American Group INC | $32.99 | 2019 | |
| Amarin Pharma, INC. | $29.37 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $28.78 | 2021 | |
| Ibsa Pharma INC. | $25.44 | 2024 | Flector, Licart, Tirosint |
| Nevro Corp. | $23.59 | 2022 | |
| Orthofix Medical, INC. | $23.58 | 2024 | Physio-Stim |
| Teleflex LLC | $20.43 | 2023 | Urolift |
| Esperion Therapeutics, INC. | $19.16 | 2025 | Nexletol |
| Spinal Simplicity, LLC | $19.15 | 2022 | |
| Amneal Pharmaceuticals LLC | $17.87 | 2024 | Unithroid |
| Globus Medical, INC. | $16.30 | 2025 | Senza |
| Tolmar, INC. | $15.36 | 2025 | Jatenzo |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.61 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.37 | 2019 | |
| Boston Scientific Corporation | $11.18 | 2019 | |
| Alfasigma USA, INC. | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Luberto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.